Does DURVALUMAB Cause Decreased appetite? 241 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 241 reports of Decreased appetite have been filed in association with DURVALUMAB (IMFINZI). This represents 1.4% of all adverse event reports for DURVALUMAB.
241
Reports of Decreased appetite with DURVALUMAB
1.4%
of all DURVALUMAB reports
53
Deaths
94
Hospitalizations
How Dangerous Is Decreased appetite From DURVALUMAB?
Of the 241 reports, 53 (22.0%) resulted in death, 94 (39.0%) required hospitalization, and 33 (13.7%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which DURVALUMAB Alternatives Have Lower Decreased appetite Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE